At TrimRx, we believe that accessing high-quality care should be straightforward, transparent, and medically supervised
Using hemoglobin A1C as a predicting model for time interval from pre-diabetes progressing to diabetes
doi: 10.1161/01.ATV.17.1.64 162 FriasJPMacaraegGBOfrecioJYuJGOlefskyJMKruszynskaYT
Industry Size (2025) USD 6556.5 Mn Forecast (2035) USD 62543.2 Mn CAGR (2025 to 2035) 25.3% GLP-1 Diabetes Treatment Drugs Market Forecast and Outlook (2025-2035) The GLP-1 diabetes treatment drugs market is expected to reach USD 6,556.5 million in 2025 and expand dramatically to USD 62,543.2 million by 2035, reflecting a compound annual growth rate (CAGR) of 25.3%
How do GLP-1 medications improve liver fat in NAFLD patients
Founded by Jerry Beinhauer, MD (CEO), Apaly builds solutions that align incentives for employers, providers, and members